Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
27862 | 180 | 39.8 | 93% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | INTERLEUKIN 32 | Author keyword | 59 | 81% | 19% | 35 |
2 | IL 32 | Author keyword | 50 | 76% | 19% | 35 |
3 | CYTOKINE IMMUNOL | Address | 9 | 44% | 9% | 16 |
4 | INTERLEUKIN 32 ALPHA | Author keyword | 3 | 100% | 2% | 3 |
5 | IL 32 BETA | Author keyword | 2 | 67% | 1% | 2 |
6 | IL 32 GAMMA TRANSGENIC MICE | Author keyword | 1 | 100% | 1% | 2 |
7 | ISOFORM INTERACTION | Author keyword | 1 | 100% | 1% | 2 |
8 | SMALL UBIQUITIN LIKE MODIFIER 2 | Author keyword | 1 | 100% | 1% | 2 |
9 | IL 32 ALPHA | Author keyword | 1 | 40% | 1% | 2 |
10 | B CELL CLL LYMPHOMA 6 | Author keyword | 1 | 50% | 1% | 1 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | INTERLEUKIN 32 | 59 | 81% | 19% | 35 | Search INTERLEUKIN+32 | Search INTERLEUKIN+32 |
2 | IL 32 | 50 | 76% | 19% | 35 | Search IL+32 | Search IL+32 |
3 | INTERLEUKIN 32 ALPHA | 3 | 100% | 2% | 3 | Search INTERLEUKIN+32+ALPHA | Search INTERLEUKIN+32+ALPHA |
4 | IL 32 BETA | 2 | 67% | 1% | 2 | Search IL+32+BETA | Search IL+32+BETA |
5 | IL 32 GAMMA TRANSGENIC MICE | 1 | 100% | 1% | 2 | Search IL+32+GAMMA+TRANSGENIC+MICE | Search IL+32+GAMMA+TRANSGENIC+MICE |
6 | ISOFORM INTERACTION | 1 | 100% | 1% | 2 | Search ISOFORM+INTERACTION | Search ISOFORM+INTERACTION |
7 | SMALL UBIQUITIN LIKE MODIFIER 2 | 1 | 100% | 1% | 2 | Search SMALL+UBIQUITIN+LIKE+MODIFIER+2 | Search SMALL+UBIQUITIN+LIKE+MODIFIER+2 |
8 | IL 32 ALPHA | 1 | 40% | 1% | 2 | Search IL+32+ALPHA | Search IL+32+ALPHA |
9 | B CELL CLL LYMPHOMA 6 | 1 | 50% | 1% | 1 | Search B+CELL+CLL+LYMPHOMA+6 | Search B+CELL+CLL+LYMPHOMA+6 |
10 | FAILURE FREQUENCIES | 1 | 50% | 1% | 1 | Search FAILURE+FREQUENCIES | Search FAILURE+FREQUENCIES |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | INTERLEUKIN 32 | 103 | 91% | 23% | 42 |
2 | IL 32 | 100 | 84% | 30% | 54 |
3 | IL 32 GAMMA | 18 | 89% | 4% | 8 |
4 | PROINFLAMMATORY CYTOKINE | 8 | 12% | 33% | 60 |
5 | STAT3 SIGNALS | 6 | 100% | 2% | 4 |
6 | PRO INFLAMMATORY PATHWAY | 4 | 75% | 2% | 3 |
7 | INTERLEUKIN 32 EXPRESSION | 2 | 67% | 1% | 2 |
8 | PANCREATIC PERIACINAR MYOFIBROBLASTS | 1 | 21% | 2% | 3 |
9 | ASPARAGUS COCHINCHINENSIS | 1 | 50% | 1% | 1 |
10 | B7 H6 | 1 | 50% | 1% | 1 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references |
% act. ref. to same field |
---|---|---|---|---|
Novel insights into the biology of interleukin-32 | 2013 | 12 | 66 | 77% |
IL-32 with potential insights into rheumatoid arthritis | 2013 | 5 | 35 | 66% |
Interleukin-32: A predominantly intracellular proinflammatory mediator that controls cell activation and cell death | 2012 | 11 | 60 | 55% |
Role of interleukin-32 in chronic rhinosinusitis | 2013 | 1 | 43 | 84% |
Important Role of the IL-32 Inflammatory Network in the Host Response against Viral Infection | 2015 | 0 | 75 | 43% |
A panoramic spectrum of complex interplay between the immune system and IL-32 during pathogenesis of various systemic infections and inflammation | 2015 | 0 | 72 | 40% |
The newest interleukins: Recent additions to the ever-growing cytokine family | 2006 | 31 | 50 | 6% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CYTOKINE IMMUNOL | 9 | 44% | 8.9% | 16 |
2 | CANC DIS EPIGENET | 1 | 50% | 0.6% | 1 |
3 | EA3948 | 1 | 50% | 0.6% | 1 |
4 | GENES ENVIRONM COMPLEX DIS | 1 | 50% | 0.6% | 1 |
5 | PRETERM BIRTH PREVENT TREATMENT UNIT | 1 | 50% | 0.6% | 1 |
6 | RADBOUD ONCOL | 1 | 50% | 0.6% | 1 |
7 | RHEUMATOLASAN MED | 0 | 33% | 0.6% | 1 |
8 | BIMC | 0 | 25% | 0.6% | 1 |
9 | CENT HOSP MINHANG DIST | 0 | 25% | 0.6% | 1 |
10 | PHYSIOPATHOL ARTHRITES | 0 | 25% | 0.6% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000099953 | THYMIC STROMAL LYMPHOPOIETIN//TSLP//THYMIC STROMAL LYMPHOPOIETIN TSLP |
2 | 0.0000088106 | IFN LAMBDA//IL 29//INTERLEUKIN 29 |
3 | 0.0000066321 | IL 27//INTERLEUKIN 27//IL 35 |
4 | 0.0000057912 | SALICYLIDENEAMINO 2 THIOPHENOL//GAMABUFOTALIN//INFLAMMATION CONTROL |
5 | 0.0000055126 | HANS WILSDORF//CLIN IMMUNOL UNITHANS WILSDORF//IMMUNOL ALLERGYCLIN IMMUNOL UNIT |
6 | 0.0000055093 | INTERLEUKIN 18//IL 18//INTERLEUKIN 18 BINDING PROTEIN |
7 | 0.0000048348 | SCHNITZLER SYNDROME//SCHNITZLERS SYNDROME//NEUTROPHILIC URTICARIAL DERMATOSIS |
8 | 0.0000041263 | BAMBOO SALT//PURPLE BAMBOO SALT//HEAT STABILIZERS FOR PVC |
9 | 0.0000037452 | PU1//SPI 1 PU1//SFPI1 PU1 |
10 | 0.0000036814 | NOD2//CARD15//NOD1 |